W2O Acquires Symplur to Innovate, Scale and Boost Accessibility of Proprietary Health Care Data and Insights Platform
Immediately improves the ability to precisely listen, target and engage key influencers, customers and stakeholders
Symplur provides an easy-to-use interface and analytical capability that will help make W2O’s data and analytics operating system and technology accessible to a broader range of non-technical users. In the future, W2O will add new features and products to the platform, which will further update and benefit its wide range of healthcare clients.
Symplur’s proprietary, purpose-built social media analytics platform, the only market-based tool of its kind designed entirely for healthcare enables rapid and easy identification of social media trends among physicians, patient advocates, life science professionals, media and other critical audiences of interest to health care organizations, government agencies, and academic institutions. In collaboration with the California Life Sciences Association, W2O and Symplur are already using the platform in conjunction with W2O’s proprietary data and technology stack to track COVID-19-specific conversations and trends across the healthcare ecosystem.
According to W2O Founder and CEO Jim Weiss, particularly in these challenging, uncertain times that reverberate across global communities and economies, healthcare companies are looking to urgently and immediately track essential information by using data and analytics to identify insights for decision-making.
Symplur’s pioneering technology products turn volumes into the most important and often overlooked voices in healthcare, ultimately paving the way for a deeper understanding of this dynamic, complex sector. Symplur is another part of a series of strategic investments in people, technology, and platforms that have made and are designed to strengthen the solutions that we provide to our clients. W2O now has hundreds of people focused on technology, data science, audience analysis, activation, and measurement and going to double down in this space.
The acquisition is designed to expand W2O’s proprietary data and technology platform and corresponding solutions, further enabling the company to combine data-rich intelligence with technology to solve customers’ problems in real-time, successfully communicate and market their product offerings and drive overall value for their brands.
Audun Utengen, co-founder and CEO of Symplur, Social Media Analytics Insights have a significant impact on the health ecosystem as a whole. Our massive Healthcare Social Graph ® platform, which uses machine learning, enables us to gather the most valuable insights to meet the needs of a wide range of healthcare clients and ultimately advance their priorities.
This work over many years has helped the company to speed up the development of relevant, powerful technology platforms such as those used to help track critical COVID-19 conversations from authentic, expert sources. Symplur’s technology and intelligence reports are currently being used by pharmaceutical companies and government agencies, including the NIH (National Institutes of Health) and the National Institute of Health.
Symplur and W2O are privately held companies, and the financial terms of the acquisitions are not disclosed. The acquisition, completed in partnership with W2O’s private equity partner, New Mountain Capital, marks the fifth acquisition of the company in nine months. Symplur, which will now operate as a W2O symplur, adds a team of experienced software architects and developers to the W2O family. The co-founders of Symplur Utengen and Thomas Lee will continue to play a leading role. They will be critical participants in the development of the company’s product audience planning suite.
